Brand Institute's Divisional President Courtney Kilroy, who manages naming projects for clients on the West Coast of the United States, has observed significantly more manufacturers initiating clinical trial naming for both Phase 2 and Phase 3 trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,